Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
about
The bromodomain: from epigenome reader to druggable targetProtein lysine acetylation by p300/CBPTargeting bromodomains: epigenetic readers of lysine acetylationAllosteric ligands for the pharmacologically dark receptors GPR68 and GPR65.Binding hotspots of BAZ2B bromodomain: Histone interaction revealed by solution NMR driven docking.Fragment-based screening of the bromodomain of ATAD2.Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.NMR-based approaches for the identification and optimization of inhibitors of protein-protein interactions.Binding Mode of Acetylated Histones to Bromodomains: Variations on a Common Motif.Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.Progress in the Development of non-BET Bromodomain Chemical Probes.Selective targeting of epigenetic reader domains.Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology.Discovery of New Bromodomain Scaffolds by Biosensor Fragment Screening.A generic protocol for protein crystal dehydration using the HC1b humidity controller.9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomainStructure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2B.Molecular basis of histone tail recognition by human TIP5 PHD finger and bromodomain of the chromatin remodeling complex NoRC.Defined PEG smears as an alternative approach to enhance the search for crystallization conditions and crystal-quality improvement in reduced screensCation-π interactions in CREBBP bromodomain inhibition: an electrostatic model for small-molecule binding affinity and selectivity.Targeting Ligandable Pockets on Plant Homeodomain (PHD) Zinc Finger Domains by a Fragment-Based Approach.A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc03115j.
P2860
Q26999935-F6D1665D-7C33-495A-B424-3634C0E93649Q27021749-3F7E2987-7E09-4704-8C46-431BEC3B148CQ28238635-986453C2-73DF-4D0F-911F-24E1CBDA7E38Q30369189-BF8139F3-1B4D-405A-8D02-3FE33F56FBE8Q30855951-FDADBD69-FE9B-4124-BEA4-C82A9E9841BCQ34631628-8D504948-7B99-46A3-833D-4AC24F8E1772Q35885359-6E4E673E-DC97-4F14-896F-1E6603297524Q36336273-B4B21EFD-16D7-40CC-9699-782A395C0A06Q36586506-D5087C07-858F-458B-A01D-1071A4FC56B8Q38203020-BF53FD0C-3D0D-4FA4-8487-F6E1C8F62059Q38512211-2B8AF378-EBE9-4A0D-9D73-205BF21942F1Q38668661-43A59105-EEC0-4D38-81BF-27C958A8DCFEQ38691377-E290501D-AF6F-4E6E-AC6D-412D57238A20Q38748150-9289C171-CFF3-4CB7-AA0B-80B3FE5CA6D8Q38837561-B69E3632-2E23-4AC1-96D8-9F11041DE364Q39085471-B684562E-2671-4A62-A429-B746ACD37998Q39799944-86B09CA3-3A98-44F2-94BF-A845D7A3E50EQ39809867-4DFEAF58-B5D3-4B74-BC00-3F68F08BA5C8Q40977903-E05E3B78-D88D-4A8D-B52E-B9FBB9A83170Q41657776-8653EC27-E7BB-4059-8728-D5EC345D1FA2Q42426261-9D274612-51AC-45E2-A9E5-9E224A490D82Q48245176-0A3A2F03-9457-425C-8274-A9695F316BBEQ52358811-4833A77E-38A9-40E7-9B71-B69E6C518A1CQ55098311-293F6B0A-0569-4CE7-981E-2581A4CBD84B
P2860
Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Targeting Low-Druggability Bro ...... against the BAZ2B Bromodomain
@ast
Targeting Low-Druggability Bro ...... against the BAZ2B Bromodomain
@en
Targeting Low-Druggability Bro ...... against the BAZ2B Bromodomain
@nl
type
label
Targeting Low-Druggability Bro ...... against the BAZ2B Bromodomain
@ast
Targeting Low-Druggability Bro ...... against the BAZ2B Bromodomain
@en
Targeting Low-Druggability Bro ...... against the BAZ2B Bromodomain
@nl
prefLabel
Targeting Low-Druggability Bro ...... against the BAZ2B Bromodomain
@ast
Targeting Low-Druggability Bro ...... against the BAZ2B Bromodomain
@en
Targeting Low-Druggability Bro ...... against the BAZ2B Bromodomain
@nl
P2093
P2860
P50
P3181
P356
P1476
Targeting Low-Druggability Bro ...... against the BAZ2B Bromodomain
@en
P2093
Ildiko Felletar
Joao R C Muniz
Martin Philpott
Tom Heightman
P2860
P304
P3181
P356
10.1021/JM401582C
P407
P577
2013-12-27T00:00:00Z